v‐src activation of the collagenase‐1 (matrix metalloproteinase‐1) promoter through PEA3 and STAT: Requirement of extracellular signal‐regulated kinases and inhibition by retinoic acid receptors

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Molecular Carcinogenesis

• Publication date

  1998-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1098-2744(199803)21:3<194::AID-MC7>3.0.CO;2-MPMID 9537651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutive Activation of JAK1 in Src-transformed Cells*

  1997cited by this paper
• The nuclear receptor corepressor SMRT inhibits interstitial collagenase (MMP-1) transcription through an HRE-independent mechanism.

  1997cited by this paper
• Cell‐type specific regulation of human interstitial collagenase‐1 gene expression by interleukin‐1β (IL‐1β) in human fibroblasts and BC‐8701 breast cancer cells

  1997cited by this paper
• The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1 Gene Expression*

  1997cited by this paper
• Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells.

  1997cited by this paper
• Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.

  1996cited by this paper
• A decade of molecular biology of retinoic acid receptors

  1996cited by this paper
• src-related tyrosine kinases regulate transcriptional activation of the interstitial collagenase gene, MMP-1, in interleukin-1-stimulated synovial fibroblasts.

  1996cited by this paper
• Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.

  1996cited by this paper
• SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers.

  1996cited by this paper
• Inhibition of rabbit collagenase (matrix metalloproteinase‐1; MMP‐1) transcription by retinoid receptors: Evidence for binding of RARs/RXRs to the −77 AP‐1 site through interactions with c‐Jun

  1996cited by this paper
• Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors

  1996cited by this paper
• Molecular mechanisms of retinoid actions in skin

  1996cited by this paper
• Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.

  1996cited by this paper
• Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability.

  1996cited by this paper
• Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.

  1996cited by this paper
• Activation and association of Stat3 with Src in v-Src-transformed cell lines

  1996cited by this paper
• Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have different effects on transcription and bind Jun D, c-Fos, and Fra-2.

  1995cited by this paper
• Selective activation of protein kinase C isoforms by v-Src.

  1995cited by this paper
• Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

  1995cited by this paper
• Suppression of collagenase gene expression by all‐trans and 9‐cis retinoic acid is ligand dependent and requires both RARs and RXRs

  1995cited by this paper
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

  1995cited by this paper
• Simian virus 40 transformation alters the actin cytoskeleton, expression of matrix metalloproteinases and inhibitors of metalloproteinases, and invasive behavior of normal and ataxia-telangiectasia human skin fibroblasts.

  1995cited by this paper
• Integration of MAP kinase signal transduction pathways at the serum response element.

  1995cited by this paper
• Proteolytic remodeling of extracellular matrix.

  1995cited by this paper
• Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

  1995cited by this paper
• Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs.

  1995cited by this paper
• Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors.

  1995cited by this paper
• v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription Factor (*)

  1995cited by this paper
• Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis

  1995cited by this paper
• A transcriptional co-repressor that interacts with nuclear hormone receptors

  1995cited by this paper
• The Retinoids : biology, chemistry, and medicine

  1994cited by this paper
• Association of the amino‐terminal half of c‐Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527.

  1994cited by this paper
• Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?

  1994cited by this paper
• JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

  1994cited by this paper
• Involvement of pp60c-src with two major signaling pathways in human breast cancer.

  1994cited by this paper
• Signal transduction by tumor necrosis factor mediated by JNK protein kinases

  1994cited by this paper
• v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element

  1994cited by this paper
• Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms.

  1994cited by this paper
• Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation.

  1994cited by this paper
• Activation of the Src family of tyrosine kinases in mammary tumorigenesis.

  1994cited by this paper
• A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum.

  1994cited by this paper
• v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters.

  1993cited by this paper
• Novel phorbol ester response region in the collagenase promoter binds Fos and Jun

  1993cited by this paper
• v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.

  1993cited by this paper
• The Src family of protein tyrosine kinases: regulation and functions.

  1993cited by this paper
• Differential regulation of collagenase gene expression by retinoic acid receptors—α, β and γ

  1992cited by this paper
• Differential regulation of collagenase gene expression by retinoic acid receptors--alpha, beta and gamma.

  1992cited by this paper
• Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src

  1992cited by this paper
• MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts.

  1992cited by this paper
• The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases.

  1992cited by this paper
• p42/mitogen-activated protein kinase as a converging target for different growth factor signaling pathways: use of pertussis toxin as a discrimination factor.

  1991cited by this paper
• The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts.

  1991cited by this paper
• The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins.

  1991cited by this paper
• Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex

  1990cited by this paper
• The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites.

  1990cited by this paper
• Oncogenic potential and normal function of the proto-oncogenes encoding protein-tyrosine kinases.

  1990cited by this paper
• Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

  1990cited by this paper
• Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5' activator protein-1-binding site.

  1990cited by this paper
• Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site.

  1990cited by this paper
• Localization by mutational analysis of transcription factor binding sequences in the U3 region of Rous sarcoma virus LTR.

  1990cited by this paper
• Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

  1990cited by this paper
• Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

  1989cited by this paper
• Advantages of firefly luciferase as a reporter gene: application to the interleukin-2 gene promoter.

  1989cited by this paper
• Differential response to retinoic acid of Syrian hamster embryo fibroblasts expressing v-src or v-Ha-ras oncogenes

  1986cited by this paper
• Isolation of a collagenase cDNA clone and measurement of changing collagenase mRNA levels during induction in rabbit synovial fibroblasts.

  1984cited by this paper

• ETV4 is a mechanical transducer linking cell crowding dynamics to lineage specification

  2024cites this paper
• SRC Signaling in Cancer and Tumor Microenvironment.

  2021cites this paper
• E2F is required for STAT3-mediated upregulation of cyclin B1 and Cdc2 expressions and contributes to G2–M phase transition

  2019cites this paper
• Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.

  2016cites this paper
• Signal Transducer and Activator of Transcription 3 Activation Promotes Invasive Growth of Colon Carcinomas through Matrix Metalloproteinase Induction 1

  2014cites this paper
• Plasticity versus specificity in RTK signalling modalities for distinct biological outcomes in motor neurons

  2014cites this paper
• MOLECULAR MECHANISMS BY WHICH c- ABL AND ARG MEDIATE MELANOMA INVASION AND METASTASIS

  2013cites this paper
• Chinese Anti鄄 Cancer a Ssociation

  2011cites this paper
• Induction of MMP-1 (collagenase-1) by relaxin in fibrocartilaginous cells requires both the AP-1 and PEA-3 promoter sites.

  2009cites this paper
• Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma

  2009cites this paper
• Extracellular Signals Regulate Rapid Coactivator Recruitment at AP-1 Sites by Altered Phosphorylation of both CREB Binding Protein and c-jun

  2008cites this paper
• Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Initiates a Dynamic Interplay between Sumoylation and Ubiquitination To Regulate the Activity of the Transcriptional Activator PEA3

  2008influential citation
• Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells.

  2008cites this paper
• Constitutive collagenase‐1 synthesis through MAPK pathways is mediated, in part, by endogenous IL‐1α during fibrotic repair in corneal stroma

  2007cites this paper
• PEA3 Is Necessary for Optimal Epidermal Growth Factor Receptor–Stimulated Matrix Metalloproteinase Expression and Invasion of Ovarian Tumor Cells

  2007cites this paper
• Signal Transducer and Activator of Transcription 3 Activation Promotes Invasive Growth of Colon Carcinomas through Matrix Metal loproteinase Induction

  2007cites this paper
• Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction.

  2007cites this paper
• Src oncogene activates MMP‐2 expression via the ERK/Sp1 pathway

  2006cites this paper
• Prostaglandin signalling and control of MMP production in human fetal membranes

  2005cites this paper
• Transcriptional activities of retinoic acid receptors.

  2005cites this paper
• Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells.

  2005cites this paper
• Alpha V Integrin Prolongs Collagenase Production Through Jun Activation Binding Protein 1

  2004cites this paper
• EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.

  2004cites this paper
• CAS promotes invasiveness of Src-transformed cells

  2004cites this paper
• The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle.

  2003cites this paper
• Interactions of STATs with Src Family Kinases

  2003cites this paper
• Src/ERK but not phospholipase D is involved in keratinocyte growth factor-stimulated secretion of matrix metalloprotease-9 and urokinase-type plasminogen activator in SNU-16 human stomach cancer cell

  2002cites this paper
• STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells

  2002cites this paper
• Macrophage Migration Inhibitory Factor Up-regulates Matrix Metalloproteinase-9 and -13 in Rat Osteoblasts

  2002cites this paper
• FRNK blocks v‐Src‐stimulated invasion and experimental metastases without effects on cell motility or growth

  2002cites this paper
• Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma

  2002influential citation
• All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline.

  2001cites this paper
• Soluble Jagged 1 Represses the Function of Its Transmembrane Form to Induce the Formation of the Src-dependent Chord-like Phenotype*

  2001cites this paper
• The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression.

  2001cites this paper
• Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta

  2001cites this paper
• A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines.

  2001cites this paper
• Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway.

  2001cites this paper
• Kinases of the Src family: structure and functions.

  2000cites this paper
• Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts.

  2000cites this paper
• Matrix metalloproteinases: pro- and anti-angiogenic activities.

  2000cites this paper
• STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells.

  1999cites this paper
• STAT 5 Activation by BCR-Abl Contributes to Transformation of K 562 Leukemia Cells

  1999cites this paper